Partnerships

The Company is involved in an alliance granting Bayer HealthCare AG worldwide exclusive rights to develop and commercialize Juvaris technology in the field of animal health, in exchange for significant upfront payments, milestone payments and future royalties on product sales. Under the terms of the agreement, Bayer HealthCare AG will have complete access to develop Juvaris' immunotherapy and vaccine technology in the field of animal health.